BNET Industries

Market Cap:$1.2B
Last Fiscal Year Sales:$250.0M
  • Public
  • US
Dow Jones Description

We are a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Our product portfolio is focused primarily on the $4.6 billion U.S. spine implant market. Additionally, we have expanded into the $1.5 billion global biologics market, the $1.5 billion international market, and are developing products for the emerging motion preservation market. Our principal product offering is based on our Maximum Access Surgery, or MAS ® platform. The MAS platform combines four categories of products that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: NeuroVision ® , a proprietary software-driven nerve avoidance system; MaXcess ® , a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platforms lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF ® , we have built an entire spine franchise. ...

CEO and Chairman
Alex Lukianov
Number of Employees 444
Contact Information

4545 Towne Centre Ct

San Diego, California 92121-1900

nuvasive.com

(858) 909-1800

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • NuVasive Names Michael Lambert CFO - Update

    11/06/09 - Board Member - Entering - View Story

  • Market Report -- In Play NUVA

    11/06/09 - Mgmt. Change Entering - Other - View Story

  • NuVasive NUVA Appoints Lambert to EVP and CFO; Makes Other Management Changes

    11/06/09 - Mgmt. Change Entering - CFO - View Story

  • BRIEF-RESEARCH ALERT-Goldman raises Edwards to buy, cuts NuVasive

    10/28/09 - Bond / Stock Rating - View Story

News & Analysis

nuvasive inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Keith Valentine President & Chief Operating Officer
Jonathan Spangler Chief Patent Counsel and Group Director of Intellectual Property
Kevin C. O'Boyle Executive Vice President & Chief Financial Officer
Kevin C. O. Boyle Chief Financial Officer and Executive Vice President
Patrick Miles Executive Vice President, Marketing & Development
Jason Hannon General Counsel, Secretary & Senior Vice President
Jeffrey Rydin Senior Vice President of U.S. Sales
Bryan Cornwall Vice President, Res & Clinical Resources
G Bryan Cornwall Vice President of Research and Clinical Resources
Lisa Brockman Vice President of Accounting
Patrick F. Williams Vice President, Finance
Roger D. Yapp Area Vice President, Central
Suzanne M. Piche Vice President, Human Resources
Steve Ogilvie Senior Director, Business Development & Investor Relations
Albert Pothier
Christian Woelk
Larry Butler
Rich Mueller
Robert J. Hunt Principal Accountant Fees and Services
Scott Durall
Terry Rich
Tyler Lipschultz
Arda M. Minocherhomjee Director
Jack R. Blair Director

Board of Directors

Name (plus bio) Position
Alex Lukianov CEO and Chairman
Lesley H. Howe Chairman
Alexis V. Lukianov CEO and Chairman
Eileen M. More Board of Directors
Hansen Yuan Board of Directors
James C. Blair Board of Directors
Joseph S. Lacob Board of Directors
Peter C. Farrell Board of Directors

Organization Position Status
NuVasive, Inc. CEO and Chairman Current
Biocom, Inc. Board of Directors Current
Ophthonix, Inc. Board of Directors Current
California Health Institute Board of Directors Current
Rutgers University Former

Keith C. Valentine has served as our President and Chief Operating Officer since January 2007. Between December 2004 and January 2007, he served as our President, and between January 2002 and December 2004, he served as our Executive Vice President. Prior to that, he served as our Sr. Vice President of Marketing and Development. With over 15 years of experience in the orthopaedic industry, Mr. Valentine has served as Vice President of Marketing at ORATEC Interventions, Inc., a medical device company which was later acquired by Smith & Nephew plc. and served in various capacities at Medtronic Sofamor Danek during his eight years with the company, including Vice President of Marketing for the Rods Division and Group Director for the BMP Biologics program, the Interbody Sales Development effort and International Sales and Marketing. Mr. Valentine received a B.B.A. in Management and Biomedical Sciences from Western Michigan University.

Organization Position Status
NuVasive, Inc. President & Chief Operating Officer Current
California Healthcare Institute, Inc. Board of Directors Current
NuVasive, Inc. Executive Vice President Former
Western Michigan University B.B.A. In Management and Biomedical Sciences Former
Western Michigan University B.B.A. In Management and Biomedical Sciences Former

Jonathan D. Spangler has served as our Vice President since December 2004 and as our Chief Patent Counsel and Group Director of Intellectual Property since September 2001. Prior to joining NuVasive, Mr. Spangler served as Chief Patent Counsel for A-Med Systems, Inc., a medical technology company. Prior to that, he practiced law at Arnold White & Durkee, specializing in patent and trade secret litigation involving medical devices, and at Haugen & Nikolai, specializing in patent prosecution involving medical devices. He also worked at the United States Patent Office, where he examined patent applications and graduated from the Patent Academy. Mr. Spangler received a B.S. in Biomedical Engineering (with a minor in Electrical Engineering) from Marquette University, and a J.D. from the University of Dayton School of Law. He is licensed to practice in California, Minnesota, and before the United States Patent and Trademark Office.

Organization Position Status
NuVasive, Inc. Chief Patent Counsel and Group Director of Intellectual Property Current
University of Dayton School of Law J.D. Former
Marquette University B.S. Degree In Biomedical Engineering Former

Kevin C. O'Boyle has served as our Chief Financial Officer since January 2003 and our Executive Vice President since December 2004. Mr. O’Boyle served in various positions during his six years with ChromaVision Medical Systems, Inc., a publicly traded medical device firm specializing in the oncology market, including as its Chief Financial Officer and Chief Operating Officer. Also, Mr. O’Boyle held various positions during his seven years with Albert Fisher North America, Inc., a publicly traded international food company, including Chief Financial Officer and Senior Vice President of Operations. Mr. O’Boyle received a B.S. in Accounting from the Rochester Institute of Technology and successfully completed the Executive Management Program at the University of California at Los Angeles, John E. Anderson Graduate Business School.

Organization Position Status
NuVasive, Inc. Executive Vice President & Chief Financial Officer Current
NuVasive, Inc. Board of Directors Current

Kevin C. O Boyle has served as our Chief Financial Officer since January 2003 and our Executive Vice President since December 2004. Mr. O Boyle served in various positions during his six years with ChromaVision Medical Systems, Inc., a publicly traded medical device firm specializing in the oncology market, including as its Chief Financial Officer and Chief Operating Officer. Also, Mr. O Boyle held various positions during his seven years with Albert Fisher North America, Inc., a publicly traded international food company, including Chief Financial Officer and Senior Vice President of Operations. Mr. O Boyle is a CPA and received a B.S. in Accounting from the Rochester Institute of Technology and successfully completed the Executive Management Program at the University of California at Los Angeles, John E. Anderson Graduate Business School.

Organization Position Status
NuVasive, Inc. Chief Financial Officer and Executive Vice President Current

Patrick Miles has served as our Executive Vice President, Product Marketing and Development since January 2007. Prior to that, he served as our Senior Vice President of Marketing from December 2004 to January 2007, and as our Vice President, Marketing from January 2001 to December 2004. Mr. Miles has over 15 years of experience in the orthopaedic industry. Mr. Miles has also served as Director of Marketing for ORATEC Interventions, Inc., a medical device company and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, as well as serving in several positions with Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.

Organization Position Status
NuVasive, Inc. Executive Vice President, Marketing & Development Current
Medtronic Sofamor Danek Inc. Director of Marketing Former
Mercer University B.S. In Finance Former

Jason M. Hannon has served as our Senior Vice President of Corporate Development, General Counsel and Secretary since January 2009. Prior to that, Mr. Hannon served as our Senior Vice President, General Counsel, and Secretary, and as our Vice President of Legal Affairs and Secretary from June 2005 to January 2009. Prior to joining NuVasive, Mr. Hannon practiced corporate and transactional law at the law firms of Brobeck Phleger & Harrison LLP and Heller Ehrman LLP, specializing in mergers and acquisitions, public and private financing, joint ventures, licensing arrangements, and corporate governance matters. Mr. Hannon also served as a law clerk to the Honorable Jerome Farris of the U.S. Court of Appeals for the Ninth Circuit. Mr. Hannon received a B.A. degree from the University of California, Berkeley and a J.D. from Stanford Law School.

Organization Position Status
NuVasive, Inc. General Counsel, Secretary & Senior Vice President Current
University of California, Berkeley B.A. Degree Former

Jeffrey P. Rydin has served as our Senior Vice President, U.S. Sales since December 2005. Prior to joining us, from January 2003 to December 2005, Mr. Rydin served as Area Vice President of Orthobiologics for DePuy Spine, Inc., a subsidiary of Johnson & Johnson. With nearly 20 years of sales experience in the healthcare industry, Mr. Rydin has also served as Vice President of Sales at Orquest, Inc., a developer of biologically-based implants for orthopaedics and spine surgery, which was acquired by DePuy, as Director of Sales at Symphonix Devices, Inc., a hearing technology company, and as Director of Sales at General Surgical Innovations, Inc., a developer, manufacturer and marketer of tissue dissection systems for minimally invasive surgical procedures, which was acquired by Tyco International Ltd. Mr. Rydin holds a B.A. in Social Ecology from the University of California, Irvine.

Organization Position Status
NuVasive, Inc. Senior Vice President of U.S. Sales Current
DePuy Spine, Inc. Area Vice President Former
Symphonix Devices, Inc Director of Sales Former
University of California, Irvine B.A. In Social Ecology Former
University of California B.A. In Social Ecology Former

Organization Position Status
NuVasive, Inc. Vice President, Res & Clinical Resources Current

Dr. Cornwall has served as Senior Vice President of Research & Clinical Resources since June 2008. From January 2004 until June 2008, he served as Vice President of Research & Development and, from 1999 to 2000, he managed NuVasive’s research efforts. Dr. Cornwall has been working in the medical device industry for more than 12 years and has been responsible for leading research and development teams in the development and testing of proprietary spinal treatment modalities with minimally invasive approaches, spinal fusion constructs, novel resorbable polymer implants, and new fracture fixation devices. Prior to rejoining NuVasive, Dr. Cornwall was with MacroPore Biosurgery for four years, most recently acting as Vice President of Research & Technology. Prior to joining NuVasive, Dr. Cornwall was with Johnson & Johnson’s trauma division, DePuy-ACE. Dr. Cornwall’s academic background includes a Bachelor of Applied Science in Mechanical Engineering, a Masters of Applied Science in Material Science, and a PhD in Mechanical Engineering, specializing in Orthopaedic Biomechanics from Queen’s University in Kingston, Ontario, Canada. He is the author of 15 peer-reviewed publications, 4 book chapters and 9 US patents.

Organization Position Status
NuVasive, Inc. Vice President of Research and Clinical Resources Current

Lisa K. Brockman has served as our Vice President of Accounting since January 2007 and served as our Group Director of Accounting from July 2005 through December 2006. From January 2001 to April 2005, she served as Assistant Corporate Controller and Director of Reporting and Research for Synopsys, Inc., a software company focused on electronic design automation. From January 1988 to December 2000, she served in various positions with Ernst & Young LLP, most recently as Senior Manager. Ms. Brockman is a certified public accountant and earned a B.A. in accounting from San Diego State University.

Organization Position Status
NuVasive, Inc. Vice President of Accounting Current
San Diego State University B.A. In Accounting Former

Organization Position Status
NuVasive, Inc. Vice President, Finance Current

Roger D. Yapp has served as our Area Vice President, Central since January 2009. Since joining NuVasive in September 2005, Mr. Yapp has served in various capacities, including most recently as our Sales Director, Great Lakes and prior to that as our Area Business Manager for Chicago. In his 20 year career in sales, with over 15 years in orthopaedic sales, Mr. Yapp has served in several positions of sales management, including positions at Kyphon Inc. and at Ethicon Endo-Surgery, a Johnson & Johnson Company. Mr. Yapp received a Bachelor of Science in Economics from University of Georgia.

Organization Position Status
NuVasive, Inc. Area Vice President, Central Current
The University of Georgia Bachelor of Science In Economics Former

Suzanne M. Piche has served as our Vice President, Human Resources, since February 2009. Prior to joining NuVasive, Ms. Piche served as the Senior Vice President, Human Resources at ChartOne, Inc., a leader in medical records workflow technology. Prior to that, she provided human resources leadership to Maine Veteransa Homes, a provider of long-term and rehabilitative care. Ms. Piche has over 23 years experience in human resources management, with 20 years as a senior human resources executive, primarily in the healthcare services field. Ms. Piche received a Mastera s degree in Business Administration from Western New England College, Massachusetts and a Bachelor of Science degree in Education from Westfield State College, Massachusetts.

Organization Position Status
NuVasive, Inc. Vice President, Human Resources Current

Organization Position Status
NuVasive, Inc. Senior Director, Business Development & Investor Relations Current

Albert Pothier has served as our Vice President, NeuroVision, a position responsible for the marketing and product development groups for our NeuroVision product line, since January 2008. Mr. Pothier originally joined NuVasive in April 2005 and has served as our Director and Group Director of Marketing, NeuroVision. In his over 15 year career in the orthopaedic industry, Mr. Pothier also worked in various positions in the marketing and development areas at Smith & Nephew, including Director of Marketing, Computer Assisted Surgery and Director of Market Development. Prior to entering the medical device field, Mr. Pothier was with the software start-up RTIS, Corp. where he held the position of Vice President of Operations. Mr. Pothier received B.S. and M.S. degrees in Mechanical/Biomedical Engineering from Worcester Polytechnic Institute, and an MBA from Christian Brothers University.

Organization Position Status
NuVasive, Inc. Current
Neuro-Vision, Inc. Vice President Former
Neuro-Vision, Inc. Group Director of Marketing Former
Computer Assisted Surgery Former
Smith & Nephew, Inc. Former
Christian Brothers University MBA Former
Worcester Polytechnic Institute M.S. Degrees In Mechanical, Biomedical Engineering Former
Worcester Polytechnic Institute B.S. Former
Christian Brothers University B.S. Former

Yoga and Fitness Professional, Christian Woelk stresses complete development of the individual through yoga, fitness, healthy nutrition and other holistic mind - body techniques. This focus on the self naturally helps to create a better physical, mental, and spiritual balance. This can also aid in an overall increase in strength, flexibility and clarity, and aid in a decrease of weight and stress levels. This style of yoga may allow you to access new levels of awareness, balance your emotions and transform "stuck" energy into productive energy. Christian's style is gentle, yet challenging: safe, yet liberating: mindful, yet spontaneous. The hope is that your experience will be a rewarding one; one in which you are inspired and educated at the same time. Christian Woelk is a nationally certified Rahini Yoga Instructor with the New York Wellness Institute and is also a registered Kundalini yoga teacher with Yoga Alliance. He has studied directly with the creator of Rahini Yoga, Dr. Dean Telano ND, PhD, MS, CNC, RYT, as well as with Gururattan Kaur Khalsa PhD, a direct disciple of Yogi Bhajan for 26 years and author of the four original Kundalini Yoga Manuals both teachers being shining lights and pioneers in their field of health, wellness, and happiness. Christian is also a member of the International Association of Yoga Therapists and is a nationally certified Personal Fitness Trainer with the American Council on Exercise. Christian develops and coordinates corporate wellness programs and is currently working with the company Nuvasive, a spinal technology company in La Jolla. Christian is the creator and director of the Rahini Yoga Space in Hillcrest and is a resident yoga teacher and fitness trainer for the Loews Coronado Resort. Christian is also creator and director for the San Diego Wellness Source, a resource for alternative and gifted health care practitioners who integrate eastern and western philosophy into their practices. He also maintains private clientele in the San Diego area.

Organization Position Status
NuVasive, Inc. Current
Ginseng Yoga Current

Larry Butler has served as our Area Vice President, Northeast since January 2009.A Since joining NuVasive in March 2001, Mr. Butler has served in several capacities, including most recently as our Senior Director, Sales, Midwest and prior to that as our Regional Sales Director and Clinical Spine Specialist.A Mr. Butler has over 20 years experience in orthopaedic sales, including 15 years in sales management. Prior to joining NuVasive, Mr. Butler served as Area Sales Manager for Oratec Interventions, Inc., a medical device company. He also worked with Mitek Surgical Products as one of the first senior managers to hire and develop their direct sales force in the Midwest.A Mr. Butler also served in a sales capacity for 5 years with Zimmer Orthopedics.A He received a BA in Economics from Virginia Military Institute.

Organization Position Status
NuVasive, Inc. Current

Rich Mueller has served as our Vice President of Product Development since January 2008.A Joining NuVasive in 2005, Mr. Mueller has served as our Director and most recently as Senior Director of Product Development. Prior to NuVasive, Mr. Mueller served as Director of Product Development at Theken Spine (currently Integra Spine), for the previous 5 years. In his over 15 year career in the health care industry, Mr. Mueller also served in a variety of Product Development capacities with Volk Optical, Procter & Gamble Company, and AcroMed Corporation (currently DePuy Spine). Mr. Mueller received his Bachelor of Science degree in Mechanical Engineering, with a biomechanics focus, from Case Western Reserve University, Cleveland, OH.

Organization Position Status
NuVasive, Inc. Current

Robert J. Hunt has served as a member of our Board of Directors since January 2005. Mr. Hunt is the co-founder of the Mercury Investment Group, an investment advisory firm established in 2002. Mr. Hunt also oversaw the finance team at AutoZone, Inc., for eight years, serving as Executive Vice President and Chief Financial Officer and director. Mr. Hunt previously held senior financial management positions at The Price Company, Malone & Hyde, Inc. and PepsiCo, Inc. He has also served as a director of SCB Computer Technology, Inc. Mr. Hunt holds bachelor and masters degrees from Columbia University and is a certified public accountant.

Organization Position Status
Mercury Investment Group, Inc. Co-Founder Current
NuVasive, Inc. Principal Accountant Fees and Services Current
NuVasive, Inc. Board of Directors Current
Columbia University Masters Degrees Former

Scott Durall has served as our Area Vice President, South, since January 2009.A From 2008 until 2009 Mr. Durall served as our Director, Sales, South.A Prior to joining NuVasive,A in a nearly 10 year career with the company, Mr. Durall was aA Director of Corporate Sales & National AccountsA at Boston Scientific Corporation. Mr. Durall has also served with Power Medical Interventions and United States Surgical Corporation, where he successfullyA earnedA regional, divisional, and corporate sales management positions. Mr. DurallA received a B.B.A. degree in Marketing from the University of Kentucky.

Organization Position Status
NuVasive, Inc. Current

Terry Rich has served as our Area Vice President, West since January 2009. Since joining NuVasive in December 2005, Mr. Rich has served most recently as Director, Sales, Northwest and prior to that as an Area Business Manager. With nearly 20 years of experience in sales, Mr. Rich has served as Distributorship Sales Manager for DePuy Spine and has also held positions at Regent Medical and at Owens & Minor. He received a Bachelor of Arts in Labor Relations from Rutgers University.

Organization Position Status
NuVasive, Inc. Current
Rutgers University Bachelor of Arts In Labor Relations Former

Tyler Lipschultz has served as our Senior Vice President, Biologics, since June 2008. Prior to joining NuVasive, Mr. Lipschultz was a Director at ProtoStar, a medical device incubator that formed Annulex, CVRx, and VERTx, which he co-founded. VERTx merged with Spine Wave in 2002 where Mr. Lipschultz subsequently served in a variety of roles at Spine Wave including Executive Vice President and General Manager of the mechanical business. Prior to ProtoStar, Mr. Lipschultz also held the position of Equity Research Analyst at Piper Jaffray and served in various marketing/product management roles at Stryker, Smith & Nephew and DePuy. Mr. Lipschultz has 20 years of orthopedic and spine experience. Mr. Lipschultz received his BA in Economics and Business Administration from Kalamazoo College and his MBA from the Executive Program at Krannert School of Management at Purdue University.

Organization Position Status
Biologics Inc. Senior Vice President Current
NuVasive, Inc. Current
The Executive Program MBA Former
Kalamazoo College BA In Economics and Business Administration Former

Organization Position Status
DJO Incorporated Chairman, Audit Committee Current
NuVasive, Inc. Chairman Current
NuVasive, Inc. Director Current
P.F. Chang's China Bistro, Inc. Board of Directors Current
KPMG International Former
Leach & Garner Company Former
DJO Incorporated Director Former

Organization Position Status
Biocom, Inc. Board of Directors Current
Ophthonix, Inc. Board of Directors Current
Volcano Corporation Board of Directors Current
NuVasive, Inc. CEO and Chairman Current
Rutgers University Former

Organization Position Status
Chicago Growth Partners Founding Partner Current
Oakwood Medical Investors Current
Genoptix, Inc. Current
Morton Grove Pharmaceuticals, Inc. Director Current
NuVasive, Inc. Director Current
Cypress Medical Products Ltd. Director Current
Inhibitex, Inc. Director Current
Favrille, Inc. Board of Directors Current
Cubic Wafer, Inc Board of Directors Current
William Blair Capital Partners Managing Member Current
William Blair & Company, L.L.C. Managing Member Current
William Blair & Company LLC Senior Health Care Analyst Former
William Blair Capital Partners managing member Former
University of Washington School of Medicine post-doctoral fellow in Pharmacology Former
Point Biomedical Corporation Board of Directors Former
University of British Columbia Ph.D Former
University of Toronto MS Former
University of British Columbia MBA Former

Eileen M. More has served as a member of our Board of Directors since June 2007. Ms. More was a General Partner at Oak Investments, one of the largest venture capital funds in the United States, for over 20 years. Ms. More founded Oak’s healthcare investment practice, and was also an active investor in information technology, with early stage investments in dozens of successful healthcare and technology companies. Her investments include leadership roles with Genzyme Corporation, Alexion Pharmaceuticals, OraPharma, Inc., Osteotech, Inc. and Compaq Computer. Ms. More retired from Oak in 2002, but continues to serve on several boards. She currently serves on the board of directors of KBL Healthcare Acquisition Corp. III, a publicly owned blank check corporation. Ms. More is Chairman Emeritus of the Connecticut Venture Group and a board member of the University of Connecticut Research and Development Corporation. Ms. More attended the University of Bridgeport and has been awarded a Chartered Financial Analyst (CFA) charter.

Organization Position Status
NuVasive, Inc. Board of Directors Current

Organization Position Status
The State University of New York Professor of Orthopedic and Neurological Surgery Current
NuVasive, Inc. Board of Directors Current
North American Spine Society President Former
Nass Second Vice President Former
University of Michigan Medical School M.D. Former

Organization Position Status
Affinergy, Inc. President of Smith & Nephew Richards Inc. and Member of the Board of Smith & Nephew Current
Inmotion: Memphis Chairman of the Board Current
NuVasive, Inc. Director Current
Buckman Laboratories Inc. Board of Directors Current
Smith & Nephew, Inc. Board of Directors Former
University of California, Los Angeles M.B.A. Former
University of California, Los Angeles B.A. In Government Former
Miami University B.A. In Government Former

Mr. Blair has been a General Partner of Domain Associates since its founding in 1985. He has over thirty years experience with venture and emerging growth companies. In the course of this experience, he has been involved with the creation and successful development as a board member of over forty life science ventures including Amgen, Amylin Pharmaceuticals, Applied Biosystems, Aurora Biosciences, Dura Pharmaceuticals, Sicor, and Molecular Dynamics. A former Managing Director of Rothschild Inc., Mr. Blair was directly involved at a senior level with Rothschild/New Court venture capital activities from 1978 to 1985. From 1969 to 1978, he was associated with F.S. Smithers and Company, and White Weld and Company, two investment banking firms actively involved with new ventures and emerging growth companies. From 1961 to 1969, Mr. Blair was an engineering manager with RCA during which time he received a David Sarnoff Fellowship. Mr. Blair is presently an Advisor to the Department of Molecular Biology at Princeton University, an Advisor to the Department of BioEngineering at the University of Pennsylvania, and he also serves on the Board of Directors of CapCure.

Organization Position Status
Genvault Corporation Partner at Domain Associates Current
Domain Inc. Partner Current
Domain Associates LLC Partner Current
Princeton University Advisory Boards Current
University of Pennsylvania Advisory Boards Current
Reebie Current
Genvault Corporation Board of Directors Current
Counselors Inc. Board of Directors Current
Zogenix, Inc. Board of Directors Current
Meritage Pharma, Inc. Board of Directors Current
Cell Biosciences, Inc. Board Member Current
Montagu Newhall Associates, Inc. Advisory Board Member Current
Five Prime Therapeutics, Inc. Board of Directors Current
Cell Biosciences, Inc Board of Directors Current
Pharmion Corporation Board of Directors Current
NuVasive, Inc. Board of Directors Current
Cadence Pharmaceuticals, Inc. Board of Directors Current
Ferrer, Freeman & Company, Inc. Board of Directors Current
Neuropace, Inc. Board Member Current
Coda Therapeutics, Inc. Board of Directors Current
Novacea, Inc. Board of Directors Current
The Prostate Cancer Foundation Board of Directors Current
Helixis, Inc. Board of Directors Current
Domain Associates LLC Managing Member Current
Rothschild Inc. Managing Director Former
RCA Corporation engineering manager Former
University of Pennsylvania Advisor Former
White, Weld and Company associated Former
Federal Highway Administration Former
General Motors Corporation Former
Consolidated Rail Corporation Former
Amgen Inc. Board Member Former
Volcano Corporation Board of Directors Former
Dura Pharmaceuticals, Inc. Board Member Former
Aurora Biosciences Corporation Board Member Former
Applied Biosystems Group Board Member Former
Sicor, Inc. Board Member Former
Amylin Pharmaceuticals, Inc. Board Member Former
Princeton University Ph.D. Former
University of Pennsylvania Ph.D Former
University of Pennsylvania M.S.E Former
The Pennsylvania State University BSc in Business Logistics Former
Princeton University B.S.E. Former

Organization Position Status
NuVasive, Inc. Board of Directors Current

Array

Organization Position Status
Sibaya Board of Directors Current
NuVasive, Inc. Board of Directors Current
UCSD-CONNECT Director Current
Pharmaxis Ltd. Board of Directors Current
ResMed, Inc. Chief Executive Officer Former
ResMed, Inc. President Former
Biomedical Engineering Foundation Director Former
University of Sydney visiting Professor Former
University Corp. D.Sc. Former
University of Sydney Masters Degrees In Chemical Engineering Former
University of Sydney B.E. In Chemical Engineering Former
University of New South Wales Former

Executive News

  • NuVasive Reports Second Quarter 2009 Financial Results

    Street Insider - 7/23/09 - View Story

  • NuVasive Reports Second Quarter 2009 Financial Results

    PR Newswire via Yahoo! - 7/23/09 - View Story

  • NuVasive Reports Second Quarter 2009 Financial Results

    NewsBlaze - 7/23/09 - View Story

advertisement
     NUVA $31.62 -0.83 (-2.56% )
Average Volume 937,207
Shares Outstanding 38.22M
Market Cap 1.2B
Year High 45.06
Year Low 24.17
Earnings Per Share 0.19
P/E Ratio 166.42
Dividend N/A
Yield N/A
advertisement